Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Part of paid clinical trials in Hackensack, New Jersey.

Sponsor
Hackensack Meridian Health
Study ID
NCT05776953
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Analgesia
  • Emergencies
  • Flank Pain
  • Renal Colic

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Ketorolac — DRUG
    IV Ketorolac for pain

Study Details

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Key Dates

Start date
Dec 21, 2023
Status verified
May 2026
Primary completion
Sep 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
86 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: 15mg IV Ketorolac
    Patients will be randomized to 15mg IV ketorolac
  • Active Comparator: 30mg IV Ketorolac
    Patients will be randomized to 30mg IV ketorolac

Primary Outcome Measure

Change in pain scale post ketorolac administration [ Time Frame: At 120 minutes (+/-10 minutes) from medication administration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Hackensack Univarsity medical CenterHackensackNew Jersey07601
Sujatha Iyengar, PhD (SUB_INVESTIGATOR)

Find similar trials in Hackensack, NJ

By research site
Hackensack Univarsity medical Center· Hackensack, NJ

Related Studies